The FDA has granted approval to an act of compassionate use treatment with the anti-cancer drug Namodenoson for a patient ...
Hosted on MSN2mon
Can-Fite BioPharma secures US patent for NamodenosonThe US Patent Office has accepted patent application No 17/309,952, titled "An A3 adenosine receptor ligand for use for achieving a fat loss effect," which is supported by the data showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback